Icariin attenuates hypoxia-induced oxidative stress and apoptosis in osteoblasts and preserves their osteogenic differentiation potential in vitro

Cell Proliferation

Volumn 47, Issue 6, 2014, Pages 527-539

  Ma, H P ^a   Ma, X N ^a   Ge, B F ^a   Zhen, P ^a   Zhou, J ^a   Gao, Y H ^a   Xian, C J ^b   Chen, K M ^a  

^a LANZHOU GENERAL HOSPITAL   (China)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; ICARIIN; LACTATE DEHYDROGENASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; CYCLINE; FLAVONOID; HERBACEOUS AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; NEWBORN; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; RAT; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; CELL CYCLE CHECKPOINT; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; EPIMEDIUM; METABOLISM; SKULL; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL DIFFERENTIATION; CELL HYPOXIA; CELLS, CULTURED; DRUGS, CHINESE HERBAL; EPIMEDIUM; FLAVONOIDS; MALONDIALDEHYDE; OSTEOBLASTS; OSTEOGENESIS; OXIDATIVE STRESS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SKULL; SUPEROXIDE DISMUTASE;

EID: 84911956037     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12147     Document Type: Article

References (45)

1. Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. 31, 266-300.
2. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP et al. (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos. Int. 8, 468-489.
3. Riggs BL, Melton LJ, Robb RA, Camp JJ, Atkinson EJ, McDaniel L et al. (2008) A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J. Bone Miner. Res. 23, 205-214.
4. Griffith JF, Kumta SM, Huang Y (2011) Hard arteries, weak bones. Skeletal Radiol. 40, 517-521.
5. London GM (2011) Soft bone - hard arteries: a link? Kidney Blood Press. Res. 34, 203-208.
6. Bridgeman G, Brookes M (1996) Blood supply to the human femoral diaphysis in youth and senescense. J. Anat. 188, 611-621.
7. Baur A, Stabler A, Bartl R, Lamerz R, Scheidler J, Reiser M (1997) MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration. Skeletal Radiol. 26, 414-418.
8. Sumino H, Ichikawa S, Kasama S, Takahashi T, Sakamoto H, Kumakura H et al. (2007) Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women. Circ. J. 71, 1555-1559.
9. Prisby RD, Ramsey MW, Behnke BJ, Dominguez JM 2nd, Donato AJ, Allen MR et al. (2007) Aging reduces skeletal blood flow, endothelium-dependent vasodilation, and NO bioavailability in rats. J. Bone Miner. Res. 22, 1280-1288.
10. Ding WG, Wei ZX, Liu JB (2011) Reduced local blood supply to the tibial metaphysis is associated with ovariectomy-induced osteoporosis in mice. Connect. Tissue Res. 52, 25-29.
11. Weinstein RS, Wan C, Liu Q, Wang Y, Almeida M, O'Brien CA et al. (2010) Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 9, 147-161.
12. Zhai YK, Guo X, Pan YL, Niu YB, Li CR, Wu XL et al. (2013) A systematic review of the efficacy and pharmacological profile of Herba Epimedii in osteoporosis therapy. Pharmazie 68, 713-722.
13. Nian H, Ma MH, Nian SS, Xu LL (2009) Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine 16, 320-326.
14. Mok SK, Chen WF, Lai WP, Leung PC, Wang XL, Yao XS et al. (2010) Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br. J. Pharmacol. 159, 939-949.
15. Li GW, Xu Z, Chang SX, Nian H, Wang XY, Qin LD (2014) Icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis. Menopause 21, 1007-1016. [Epub ahead of print]
16. Zhang G, Qin L, Shi Y (2007) Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. J. Bone Miner. Res. 22, 1072-1079.
17. Zhang D, Zhang J, Fong C, Yao X, Yang M (2012) Herba epimedii flavonoids suppress osteoclastic differentiation and bone resorption by inducing G2/M arrest and apoptosis. Biochimie 94, 2514-2522.
18. Song L, Zhao J, Zhang X, Li H, Zhou Y (2013) Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation. Eur. J. Pharmacol. 714, 15-22.
19. Ma HP, Ming LG, Ge BF, Zhai YK, Song P, Xian CJ et al. (2011) Icarrin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J. Cell. Biochem. 112, 916-923.
20. Ming LG, Chen KM, Xian CJ (2013) Function and action mechanism of flavoids genistein and icariin in regulating bone remodeling. J. Cell. Physiol. 228, 513-521.
21. Messner B, Ploner C, Laufer G, Bernhard D (2012) Cadmium activates a programmed, lysosomal membrane permeabilization-dependent necrosis pathway. Toxicol. Lett. 212, 268-275.
22. Zhou J, Ming LG, Ge BF, Wang JQ, Zhu RQ, Wei Z et al. (2011) Effects of 50Hz sinusoidal electromagnetic fields of different intensities on proliferation, differentiation and mineralization potentials of rat osteoblasts. Bone 49, 753-761.
23. Miura T, Tanno M (2010) Mitochondria and GSK-3β in cardioprotection against ischemia/reperfusion injury. Cardiovasc. Drugs Ther. 24, 255-263.
24. Kim JY, Park JH (2003) ROS-dependent caspase-9 activation in hypoxic cell death. FEBS Lett. 549, 94-98.
25. Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H (2001) Association between oxidative stress and bone mineral density. Biochem. Biophys. Res. Commun. 288, 275-279.
26. Jagger CJ, Lean JM, Davies JT, Chambers TJ (2005) Tumor necrosis factor-α mediates osteopenia caused by depletion of antioxidants. Endocrinology 146, 113-118.
27. Altindag O, Erel O, Soran N, Celik H, Selek S (2008) Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol. Int. 28, 317-321.
28. Pasco JA, Henry MJ, Wilkinson LK, Nicholson GC, Schneider HG, Kotowicz MA (2006) Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women. J. Womens. Health (Larchmt) 15, 295-300.
29. Sanders KM, Kotowicz MA, Nicholson GC (2007) Potential role of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal women: a pilot study. Trans. Res. 150, 215.
30. Liu ZQ (2006) Icariin: a special antioxidant to protect linoleic acid against free-radical-induced peroxidation in micelles. J. Phys. Chem. A 110, 6372-6378.
31. Wang YK, Huang ZQ (2005) Protective effects of icariin on human umbilical vein endothelial cell injury induced by H2O2 in vitro. Pharmacol. Res. 52, 174-182.
32. Liu ZQ, Luo XY, Sun YX, Wu W, Liu CM, Liu ZQ et al. (2004) The antioxidative effect of icariin in human erythrocytes against free-radical-induced haemolysis. J. Pharm. Pharmacol. 56, 1557-1562.
33. Zhao F, Tang YZ, Liu ZQ (2007) Protective effect of icariin on DNA against radical-induced oxidative damage. J. Pharm. Pharmacol. 59, 1729-1732.
34. Xu RX, Wu Q, Luo Y, Gong QH, Yu LM, Huang XN et al. (2009) Protective effects of icariin on cognitive deficits induced by chronic cerebral hypoperfusion in rats. Clin. Exp. Pharmacol. Physiol. 36, 810-815.
35. Zhang L, Huang S, Chen Y, Wang Z, Li E, Xu Y (2010) Icariin inhibits hydrogen peroxide-mediated cytotoxicity by up-regulating sirtuin type 1-dependent catalase and peroxiredoxin. Basic Clin. Pharmacol. Toxicol. 107, 899-905.
36. Zhang Q, Li H, Wang S, Liu M, Feng Y, Wang X (2013) Icariin protects rat cardiac H9c2 cells from apoptosis by inhibiting endoplasmic reticulum stress. Int. J. Mol. Sci. 14, 17845-17860.
37. Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21, 115-137.
38. Jilka RL, Bellido T, Almeida M, Plotkin LI, O'Brien CA, Weinstein RS et al. (2008). Apoptosis and bone cells. In: Bilezikian JP, Raisz LG, Martin T, eds. Principles of Bone Biology, pp. 235-259. San Diego, CA: Academic Press.
39. Ma XN, Zhou J, Ge BF, Zhen P, Ma HP, Shi WG et al. (2013) Icariin induces osteoblast differentiation and mineralization without dexamethasone in vitro. Planta Med. 79, 1501-1508.
40. Williams RJ, Spencer JPE, Rice-Evans C (2004) Flavonoids: antioxidants or signaling molecules? Free. Radical. Bio. Med. 36, 838-849.
41. Tseng PC, Hou SM, Chen RJ, Peng HW, Hsieh CF, Kuo ML et al. (2011) Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating Runx2 gene expression via the Sirt1/Foxo3A axis. J. Bone Miner. Res. 26, 2552-2563.
42. Wu J, Xu H, Wong PF, Xia S, Xu J, Dong J (2014) Icaritin attenuates cigarette smoke-mediated oxidative stress in human lung epithelial cells via activation of PI3K-AKT and Nrf2 signaling. Food Chem. Toxicol. 64, 307-313.
43. Huang XS, Chen HP, Yu HH, Yan YF, Liao ZP, Huang QR (2014) Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for hypoxic preconditioning-mediated delayed cardioprotection. Mol. Cell. Biochem. 385, 33-41.
44. Kaelin WG Jr, Ratcliffe PJ (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393-402.
45. Kiani AA, Kazemi A, Halabian R, Mohammadipour M, Jahanian-Najafabadi A, Roudkenar MH (2013) HIF-1α confers resistance to induced stress in bone marrow-derived mesenchymal stem cells. Arch. Med. Res. 44, 185-193.